CoChat

Interaction of SHP‐2 SH2 domains with PD‐1 ITSM induces PD‐1 dimerization and SHP‐2 activation

Open access
Patsoukis, Nikolaos, Duke-Cohan, Jonathan S., Chaudhri, Apoorvi, Aksoylar, Halil-Ibrahim, Wang, Qi, Council, Asia, Berg, Anders, Freeman, Gordon J., Boussiotis, Vassiliki A. · 2020 · Communications Biology

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Programmed cell death-1 (PD-1) inhibits T cell responses. This function relies on interaction with SHP-2. PD-1 has one immunoreceptor tyrosine-based inhibitory motif (ITIM) at Y223 and one immunoreceptor tyrosine-based switch motif (ITSM) at Y248. Only ITSM-Y248 is indispensable for PD-1-mediated inhibitory function but how SHP-2 enzymatic activation is mechanistically regulated by one PD-1 phosphotyrosine remains a puzzle. We found that after PD-1 phosphorylation, SHP-2 can bridge phosphorylated ITSM-Y248 residues on two PD-1 molecules via its amino terminal (N)-SH2 and carboxyterminal (C)-SH2 domains forming a PD-1: PD-1 dimer in live cells. The biophysical ability of SHP-2 to interact with two ITSM-pY248 residues was documented by isothermal titration calorimetry. SHP-2 interaction with two ITSM-pY248 phosphopeptides induced robust enzymatic activation. Our results unravel a mechanism of PD-1: SHP-2 interaction that depends only on ITSM-Y248 and explain how a single docking site within the PD-1 cytoplasmic tail can activate SHP-2 and PD-1-mediated inhibitory function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-020-0845-0

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Phosphorylation of PD-1 ITSM Y248 by TCR proximal Src family kinases Fyn and Lck, but not ZAP-70 is required for interaction with SHP-2. a Jurkat-PD1 cells were left unstimulated or stimulated with aCD3/CD28/IgG or aCD3/CD28/PDL1-Ig beads for the indicated times, lysates were prepared followed by immunoprecipitation with anti-PD-1 antibody, SDS-PAGE, and western blot with antibodies for SHP-2 and PD-1. SHP-2 expression in whole-cell lysates was examined. b COS cells were co-transfected with PD-1, SHP-2, and either the kinase active (+) or inactive (–) form of either Fyn, Lck, or ZAP-70. After PD-1 immunoprecipitation of cell lysates and SDS-PAGE, immunoblot was performed with antibodies for SHP-2, PD-1, or an antibody specific for phosphorylated tyrosine of PD-1 ITSM Y248. Expression of the indicated proteins in the same whole-cell lysates was assessed. c COS cells were co-transfected with SHP-2, Fyn kinase active and either PD-1 wild type, PD-1 Y223F, PD-1 Y248F, or PD-1 Y223F/Y248F. PD-1 immunoprecipitation was performed in cell lysates followed by SDS-PAGE and immunoblot with the indicated antibodies. Expression of the same proteins in the same whole-cell lysates was assessed. Results are representative of five independent experiments.
Fig. 1 Phosphorylation of PD-1 ITSM Y248 by TCR proximal Src family kinases Fyn and Lck, but not ZAP-70 is required for interaction with SHP-2. a Jurkat-PD1 cells were left unstimulated or stimulated with aCD3/CD28/IgG or aCD3/CD28/PDL1-Ig beads for the indicated times, lysates were prepared followed by immunoprecipitation with anti-PD-1 antibody, SDS-PAGE, and western blot with antibodies for SHP-2 and PD-1. SHP-2 expression in whole-cell lysates was examined. b COS cells were co-transfected with PD-1, SHP-2, and either the kinase active (+) or inactive (–) form of either Fyn, Lck, or ZAP-70. After PD-1 immunoprecipitation of cell lysates and SDS-PAGE, immunoblot was performed with antibodies for SHP-2, PD-1, or an antibody specific for phosphorylated tyrosine of PD-1 ITSM Y248. Expression of the indicated proteins in the same whole-cell lysates was assessed. c COS cells were co-transfected with SHP-2, Fyn kinase active and either PD-1 wild type, PD-1 Y223F, PD-1 Y248F, or PD-1 Y223F/Y248F. PD-1 immunoprecipitation was performed in cell lysates followed by SDS-PAGE and immunoblot with the indicated antibodies. Expression of the same proteins in the same whole-cell lysates was assessed. Results are representative of five independent experiments.CC BY · PubMed Central
Fig. 2 Interaction of both SH2 domains of SHP-2 is required for SHP-2 binding to PD-1. a COS cells were transfected with kinase active Fyn, PD-1 WT and either SHP-2-WT, SHP-2-R32A, or SHP-2-R138A mutants FLAG-tagged; Fyn, PD-1-Y223F and either SHP-2-WT, SHP-2-R32A, or SHP-2-R138A mutants FLAG-tagged; or Fyn, PD-1-Y248F and either SHP-2-WT, SHP-2-R32A, or SHP-2-R138A mutants FLAG-tagged. Immunoprecipitation of cell lysates was performed with anti-PD-1 antibody followed by SDS-PAGE and immunoblot with FLAG- or PD-1-specific antibodies. Expression of the indicated proteins in the same whole-cell lysates was assessed. Results are representative of four separate experiments. b ITSM-pY248 but not ITIM-pY223 phosphopeptide binds with SHP-2 SH2 domains. For assessment of ITIM-pY223 and ITSM-pY248 binding to SHP-2 SH2 domains, SHP-2 amino acids 1–225, which only contains the tandem N-SH2 and C-SH2 domains in their natural sequence (referred to as t-SHP-2), was used. 2 µM of t-SHP-2 were mixed with either ITIM-pY223 or ITSM-pY248 phosphopeptides at the indicated molar ratios, incubated for 1 h at room temperature and binding was examined by Native PAGE followed by Coomassie blue staining. c t-SHP-2 was mixed with a phosphopeptide corresponding to the native sequence of PD-1 cytoplasmic tail in which either both ITIM-Y223 and ITSM-Y248, only the ITIM-Y223, or only the ITSM-Y248 tyrosines were phosphorylated (PD-1cyto-pITIM-pITSM, PD-1cyto-pITIM-ITSM, and PD-1cyto-ITIM-pITSM, respectively). 2μM of t-SHP-2 were mixed with each of the phosphopeptides at the indicated molar ratios, incubated for 1 h hour at room temperature and binding was examined by Native PAGE followed by Coomassie blue staining. d, e Tentative models of PD-1: SHP-2 interaction after PD-1 phosphorylation.
Fig. 2 Interaction of both SH2 domains of SHP-2 is required for SHP-2 binding to PD-1. a COS cells were transfected with kinase active Fyn, PD-1 WT and either SHP-2-WT, SHP-2-R32A, or SHP-2-R138A mutants FLAG-tagged; Fyn, PD-1-Y223F and either SHP-2-WT, SHP-2-R32A, or SHP-2-R138A mutants FLAG-tagged; or Fyn, PD-1-Y248F and either SHP-2-WT, SHP-2-R32A, or SHP-2-R138A mutants FLAG-tagged. Immunoprecipitation of cell lysates was performed with anti-PD-1 antibody followed by SDS-PAGE and immunoblot with FLAG- or PD-1-specific antibodies. Expression of the indicated proteins in the same whole-cell lysates was assessed. Results are representative of four separate experiments. b ITSM-pY248 but not ITIM-pY223 phosphopeptide binds with SHP-2 SH2 domains. For assessment of ITIM-pY223 and ITSM-pY248 binding to SHP-2 SH2 domains, SHP-2 amino acids 1–225, which only contains the tandem N-SH2 and C-SH2 domains in their natural sequence (referred to as t-SHP-2), was used. 2 µM of t-SHP-2 were mixed with either ITIM-pY223 or ITSM-pY248 phosphopeptides at the indicated molar ratios, incubated for 1 h at room temperature and binding was examined by Native PAGE followed by Coomassie blue staining. c t-SHP-2 was mixed with a phosphopeptide corresponding to the native sequence of PD-1 cytoplasmic tail in which either both ITIM-Y223 and ITSM-Y248, only the ITIM-Y223, or only the ITSM-Y248 tyrosines were phosphorylated (PD-1cyto-pITIM-pITSM, PD-1cyto-pITIM-ITSM, and PD-1cyto-ITIM-pITSM, respectively). 2μM of t-SHP-2 were mixed with each of the phosphopeptides at the indicated molar ratios, incubated for 1 h hour at room temperature and binding was examined by Native PAGE followed by Coomassie blue staining. d, e Tentative models of PD-1: SHP-2 interaction after PD-1 phosphorylation.CC BY · PubMed Central
Fig. 3 Surface plasmon resonance (SPR) and isothermal titration calorimetry analysis of SHP-2 interaction with PD-1. a PD-1 phosphotyrosyl ITSM-Y248 peptide was immobilized on a CM5 BIAcore chip and binding of SHP-2 full-length SHP-2-N-SH2, and SHP-2-C-SH2, all at 320 nM, was determined by SPR. Full binding curves are presented in Supplementary Fig. 8. Sensograms of 900 s (15 min) association and 900 s dissociation time were analyzed and KD values were calculated. b PD-1 phosphotyrosyl ITIM-Y223 peptide was immobilized on a CM5 BIAcore chip and binding of SHP-2-full-length at the indicated concentrations, was determined by SPR. Results are representative of three experiments. c, d Isothermal titration calorimetry (ITC) experiments were performed on a MicroCal ITC200 instrument. PD-1 phosphopeptides (PD-1cyto-pITIM-pITSM and PD-1cyto-ITIM-pITSM) and t-SHP-2 protein were prepared in buffer containing 50 mM HEPES pH 7.4, 100 mM NaCl, 5 mM TCEP and stoichiometry of bisphosphorylated PD-1 peptide: t-SHP-2 interaction was assessed as described in Methods.
Fig. 3 Surface plasmon resonance (SPR) and isothermal titration calorimetry analysis of SHP-2 interaction with PD-1. a PD-1 phosphotyrosyl ITSM-Y248 peptide was immobilized on a CM5 BIAcore chip and binding of SHP-2 full-length SHP-2-N-SH2, and SHP-2-C-SH2, all at 320 nM, was determined by SPR. Full binding curves are presented in Supplementary Fig. 8. Sensograms of 900 s (15 min) association and 900 s dissociation time were analyzed and KD values were calculated. b PD-1 phosphotyrosyl ITIM-Y223 peptide was immobilized on a CM5 BIAcore chip and binding of SHP-2-full-length at the indicated concentrations, was determined by SPR. Results are representative of three experiments. c, d Isothermal titration calorimetry (ITC) experiments were performed on a MicroCal ITC200 instrument. PD-1 phosphopeptides (PD-1cyto-pITIM-pITSM and PD-1cyto-ITIM-pITSM) and t-SHP-2 protein were prepared in buffer containing 50 mM HEPES pH 7.4, 100 mM NaCl, 5 mM TCEP and stoichiometry of bisphosphorylated PD-1 peptide: t-SHP-2 interaction was assessed as described in Methods.CC BY · PubMed Central
Fig. 4 SHP-2 bridges two PD-1 molecules via PD-1 ITSM pY248. a The NanoBiT proximity assay: PD-1-LgBiT and PD-1-SmBiT induce luciferase activity only if two PD-1 molecules stably interact resulting in the formation of an active luciferase enzyme. b HEK-293 cells were co-transfected as indicated and luciferase activity was assessed. Comparisons were performed by two-way ANOVA and Tukey’s multiple comparisons test (****P < 0.0001, PD1sm + PD1Lg + SHP2WT + Fyn(+) vs. all other samples, **P < 0.005, PD1sm + PD1Lg + SHP2R32A + Fyn(+) vs. PD1sm + PD1Lg + SHP2DM + Fyn(+), n = 6 experiments). c HEK-293 cells were co-transfected with the indicated constructs together with either kinase active (+) or inactive (-) Fyn and luciferase activity was assessed (****P < 0.0001, n = 3 experiments). d HEK-293 cells co-transfected with PD1SmBiT, PD1LgBiT and SHP-2 WT, together with either kinase active (+) or inactive (−) Fyn, were cultured in the presence of hPD-L1-Ig (dimer), hPD-L1 monomer or control IgG and luciferase activity was assessed (*P < 0.05, n = 3 experiments). e HEK-293 cells co-transfected with PD1SmBiT, PD1LgBiT, SHP-2 WT, and kinase active Fyn were cultured in the presence of increasing amounts of the allosteric SHP-2 inhibitor SHP099 or vehicle control (0) and luciferase activity was assessed (arrow indicates baseline luciferase activity). f The BiFC assay is based on structural complementation of two non-fluorescent N- and C-terminal fragments of Venus YFP-fluorescent protein fused to a pair of interacting proteins. g HEK-293 cells transfected with indicated constructs were analyzed by confocal microscopy. Representative fluorescent images of each indicated transfection condition. Polymerized actin was visualized with rhodamine-conjugated phalloidin. YFP signal from PD1-VN + PD1-VC complementation was visualized in the green channel. Intensity of yellow color in the merged images is indicative of co-localization of PD-1 dimer with the actin cytoskeleton. h Quantitative analysis of images from g and comparison of total corrected cellular YFP fluorescence (TCCF-YFP) in the indicated conditions after subtraction of TCCF-YFP from control transfection PD1-VN + PD1-VC + 2xVector, **P < 0.005, n = 50 from one of two independent experiments. i Primary human T cells co-transfected with PD1SmBiT, PD1LgBiT and the indicated SHP-2 constructs were cultured with Raji-PD-L1 with or without prior loading with SEE and luciferase activity was assessed 6 h later (****P < 0.0001, ***P < 0.0005, **P < 0.005, *P < 0.05, n = 3 experiments).
Fig. 4 SHP-2 bridges two PD-1 molecules via PD-1 ITSM pY248. a The NanoBiT proximity assay: PD-1-LgBiT and PD-1-SmBiT induce luciferase activity only if two PD-1 molecules stably interact resulting in the formation of an active luciferase enzyme. b HEK-293 cells were co-transfected as indicated and luciferase activity was assessed. Comparisons were performed by two-way ANOVA and Tukey’s multiple comparisons test (****P < 0.0001, PD1sm + PD1Lg + SHP2WT + Fyn(+) vs. all other samples, **P < 0.005, PD1sm + PD1Lg + SHP2R32A + Fyn(+) vs. PD1sm + PD1Lg + SHP2DM + Fyn(+), n = 6 experiments). c HEK-293 cells were co-transfected with the indicated constructs together with either kinase active (+) or inactive (-) Fyn and luciferase activity was assessed (****P < 0.0001, n = 3 experiments). d HEK-293 cells co-transfected with PD1SmBiT, PD1LgBiT and SHP-2 WT, together with either kinase active (+) or inactive (−) Fyn, were cultured in the presence of hPD-L1-Ig (dimer), hPD-L1 monomer or control IgG and luciferase activity was assessed (*P < 0.05, n = 3 experiments). e HEK-293 cells co-transfected with PD1SmBiT, PD1LgBiT, SHP-2 WT, and kinase active Fyn were cultured in the presence of increasing amounts of the allosteric SHP-2 inhibitor SHP099 or vehicle control (0) and luciferase activity was assessed (arrow indicates baseline luciferase activity). f The BiFC assay is based on structural complementation of two non-fluorescent N- and C-terminal fragments of Venus YFP-fluorescent protein fused to a pair of interacting proteins. g HEK-293 cells transfected with indicated constructs were analyzed by confocal microscopy. Representative fluorescent images of each indicated transfection condition. Polymerized actin was visualized with rhodamine-conjugated phalloidin. YFP signal from PD1-VN + PD1-VC complementation was visualized in the green channel. Intensity of yellow color in the merged images is indicative of co-localization of PD-1 dimer with the actin cytoskeleton. h Quantitative analysis of images from g and comparison of total corrected cellular YFP fluorescence (TCCF-YFP) in the indicated conditions after subtraction of TCCF-YFP from control transfection PD1-VN + PD1-VC + 2xVector, **P < 0.005, n = 50 from one of two independent experiments. i Primary human T cells co-transfected with PD1SmBiT, PD1LgBiT and the indicated SHP-2 constructs were cultured with Raji-PD-L1 with or without prior loading with SEE and luciferase activity was assessed 6 h later (****P < 0.0001, ***P < 0.0005, **P < 0.005, *P < 0.05, n = 3 experiments).CC BY · PubMed Central
Fig. 5 Interaction of SHP-2 SH2 domains with two PD-1 ITSM pY248 residues is required for activation of SHP-2 phosphatase activity. a SHP-2-WT was incubated with 20 µM DiFMUP as substrate in the presence of the indicated phosphopeptides and phosphatase activity was assessed as described in Methods. b Phosphatase activity of SHP-2-WT incubated with bpITSM phosphotyrosyl peptides containing a 4-, 2-, or 1-Ahx spacer; pIRSY727 was used as negative control. c Phosphatase activity of SHP-2-WT, SHP-2-R32A, or SHP-2-R138A incubated with the indicated concentrations of bpITSM phosphotyrosyl peptide containing a 4-Ahx spacer. d Phosphatase activity of SHP-2-WT in the presence of phosphotyrosyl bpITSM peptide (0.01 µM) either alone or with increasing amounts of monophosphorylated pITIM or monophosphorylated pITSM peptide. Results are representative of three independent experiments. e Phosphatase activity of SHP-2-WT in the presence of a phosphopeptide corresponding to the native sequence of PD-1 cytoplasmic tail in which both ITIM-Y223 and ITSM-Y248 tyrosines were phosphorylated (PD-1cyto-pITIM-pITSM) or with a bpITSM phosphotyrosyl peptide containing a 10-Ahx spacer. pIRSY727 was used as negative control. In panels a–e results from one representative of 3–10 independent experiments are shown. f Jurkat T cells stably expressing PD-1-WT (J-PD-1), PD-1-Y223F (J-PD-1-Y223F), or PD-1-Y248F (J-PD-1-Y248F) were co-cultured with Raji-control or Raji-PD-L1 cells loaded with SEE. Where indicated, anti-PD-1 blocking antibody or isotype control was added in the cultures. Culture supernatants were collected at 24 h and IL-2 production was measured. Results are expressed as % of maximum IL-2 production induced in each cell line by Raji-control cells loaded with SEE (****P < 0.0001, n = 3 experiments). g Model for PD-1: PD-1 bridging and activation of SHP-2 phosphatase activity: An “inside-out” regulation of PD-1: PD-1 dimer complex formation is initiated by TCR-mediated activation of TCR proximal Src family kinases, which induce phosphorylation of tyrosines in PD-1 cytoplasmic tail. The stabilization provided by PD-1 ligands allows the appropriate proximity of two phosphorylated PD-1 molecules to induce binding of both SH2 domains of SHP-2 to ITSM-pY248 and activation of SHP-2, leading to inhibition of T-cell responses.
Fig. 5 Interaction of SHP-2 SH2 domains with two PD-1 ITSM pY248 residues is required for activation of SHP-2 phosphatase activity. a SHP-2-WT was incubated with 20 µM DiFMUP as substrate in the presence of the indicated phosphopeptides and phosphatase activity was assessed as described in Methods. b Phosphatase activity of SHP-2-WT incubated with bpITSM phosphotyrosyl peptides containing a 4-, 2-, or 1-Ahx spacer; pIRSY727 was used as negative control. c Phosphatase activity of SHP-2-WT, SHP-2-R32A, or SHP-2-R138A incubated with the indicated concentrations of bpITSM phosphotyrosyl peptide containing a 4-Ahx spacer. d Phosphatase activity of SHP-2-WT in the presence of phosphotyrosyl bpITSM peptide (0.01 µM) either alone or with increasing amounts of monophosphorylated pITIM or monophosphorylated pITSM peptide. Results are representative of three independent experiments. e Phosphatase activity of SHP-2-WT in the presence of a phosphopeptide corresponding to the native sequence of PD-1 cytoplasmic tail in which both ITIM-Y223 and ITSM-Y248 tyrosines were phosphorylated (PD-1cyto-pITIM-pITSM) or with a bpITSM phosphotyrosyl peptide containing a 10-Ahx spacer. pIRSY727 was used as negative control. In panels a–e results from one representative of 3–10 independent experiments are shown. f Jurkat T cells stably expressing PD-1-WT (J-PD-1), PD-1-Y223F (J-PD-1-Y223F), or PD-1-Y248F (J-PD-1-Y248F) were co-cultured with Raji-control or Raji-PD-L1 cells loaded with SEE. Where indicated, anti-PD-1 blocking antibody or isotype control was added in the cultures. Culture supernatants were collected at 24 h and IL-2 production was measured. Results are expressed as % of maximum IL-2 production induced in each cell line by Raji-control cells loaded with SEE (****P < 0.0001, n = 3 experiments). g Model for PD-1: PD-1 bridging and activation of SHP-2 phosphatase activity: An “inside-out” regulation of PD-1: PD-1 dimer complex formation is initiated by TCR-mediated activation of TCR proximal Src family kinases, which induce phosphorylation of tyrosines in PD-1 cytoplasmic tail. The stabilization provided by PD-1 ligands allows the appropriate proximity of two phosphorylated PD-1 molecules to induce binding of both SH2 domains of SHP-2 to ITSM-pY248 and activation of SHP-2, leading to inhibition of T-cell responses.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 1

  1. Bardhan, K., Weaver, D. J., Strauss, L., Patsoukis, N. & Boussiotis, A. V. Phosphorylation of Y248 in the ITSM of PD-1 is indicative of PD-1-mediated inhibitory function. J. Immunol. 194, 154.159 (Abstr.) (2017).

Cited by

See all 182

Metadata

Authors
Patsoukis, N., Duke-Cohan, J. S., Chaudhri, A., Aksoylar, H.-I., Wang, Q., Council, A., Berg, A., Freeman, G. J., & Boussiotis, V. A.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • Cedars-Sinai Medical Center (US)
  • Harvard University (US)
Corresponding author
Boussiotis, Vassiliki A.
Venue
Communications Biology
Published
2020-03-17
Volume
3
Issue
1
Pages
128-128
ISSN
2399-3642 (ISSN-L)
OpenAlex
W3011824547
Cited by
169
References
67
Citations by year
2026: 27 · 2025: 30 · 2024: 26 · 2023: 31 · 2022: 22 · 2021: 25 · 2020: 8
FWCI
6.98
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (P50CA101942 and P01AI056299)
  • National Cancer Institute (R01CA183605, P50CA101942, R01CA238263, R01CA212605)
  • National Institute of Allergy and Infectious Diseases (P01AI056299)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR073494)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
PD-1, SHP2, SH2 domain, IT service management, ITIM, T cell suppression, receptor tyrosine phosphatase, protein-protein interaction
MeSH terms
Animals, Chlorocebus aethiops, Enzyme Activation, Humans, Phosphorylation, Protein Binding, T-Lymphocytes, Mice, Knockout, src Homology Domains, Jurkat Cells, COS Cells, Proto-Oncogene Proteins c-fyn, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Protein Multimerization, HEK293 Cells, Programmed Cell Death 1 Receptor, Immunoreceptor Tyrosine-Based Activation Motif

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interaction of SHP‐2 SH2 domains with PD‐1 ITSM induces PD‐1 dimerization and SHP‐2 activation. https://app.cochat.ai/papers/10.1038/s42003-020-0845-0
The paper
Patsoukis, N., Duke-Cohan, J. S., Chaudhri, A., Aksoylar, H.-I., Wang, Q., Council, A., Berg, A., Freeman, G. J., & Boussiotis, V. A. (2020). Interaction of SHP‐2 SH2 domains with PD‐1 ITSM induces PD‐1 dimerization and SHP‐2 activation. Communications Biology. https://doi.org/10.1038/s42003-020-0845-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.